(Q36222935)

12 August 2017

Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes (English)

1 reference

12 August 2017

0 references

8

Hagop Kantarjian

1 reference

12 August 2017

10

Donna Neuberg

1 reference

PMCID

3438234

12 August 2017

Guillermo Garcia-Manero

series ordinal

11

object named as

Guillermo Garcia-Manero

1 reference

12 August 2017

9

Ross L Levine

1 reference

12 August 2017

7

Azra Raza

1 reference

12 August 2017

5

David P Steensma

1 reference

12 August 2017

4

Omar Abdel-Wahab

1 reference

12 August 2017

12

Benjamin L Ebert

1 reference

12 August 2017

1

Rafael Bejar

1 reference

12 August 2017

2

Kristen E Stevenson

1 reference

12 August 2017

6

Naomi Galili

1 reference

12 August 2017

3

Bennett A Caughey

1 reference

PMCID

3438234

12 August 2017

language of work or name

English

0 references

publication date

6 August 2012

1 reference

Journal of Clinical Oncology

12 August 2017

1 reference

12 August 2017

30

1 reference

12 August 2017

3376-3382

1 reference

12 August 2017

27

1 reference

Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438234

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438234

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438234

Validation of the MD Anderson Prognostic Risk Model for patients with myelodysplastic syndrome.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438234

Frequent pathway mutations of splicing machinery in myelodysplasia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438234

Clinical effect of point mutations in myelodysplastic syndromes

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438234

Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438234

Recurrent DNMT3A mutations in patients with myelodysplastic syndromes

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438234

NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438234

The epidemiology of myelodysplastic syndromes

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438234

Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438234

Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438234

The incidence and impact of thrombocytopenia in myelodysplastic syndromes

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438234

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438234

International scoring system for evaluating prognosis in myelodysplastic syndromes

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438234

A prognostic score for patients with lower risk myelodysplastic syndrome

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438234

Platelet count is an IPSS-independent risk factor predicting survival in refractory anaemia with ringed sideroblasts

22 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22869879

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1200/JCO.2011.40.7379

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

PMCID

3438234